# Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/systematic-review-and-network-meta-analysis-comparing-ocrelizumab-with-other/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rachael McCool,Katy Wilson,Mick Arber,Kelly Fleetwood,Sydney Toupin,Howard Thom,Iain Bennett,Susan Edwards |
| Citations | 111 |
| DOI | 10.1016/j.msard.2018.12.040 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.msard-journal.com/article/S2211034818305807/pdf |
| OpenAlex ID | https://openalex.org/W2906720084 |
| PMID | 30677733 |
| Type | review |
| Year | 2019 |

## Paper authors

- [Howard Thom](https://scholariq.org/researchers/howard-thom/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.